A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug resistance.

For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...

Antibiotic resistance is one of the world's leading causes of death, claiming the lives of more people than HIV / AIDS or ...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If ...

New ‘nanoagents’ can carry drugs straight to infected areas with minimal amounts of drug - reducing the risks of antibiotic resistance.

Accurately modeling irregularly-shaped particles isn’t easy, but a new study found a way to improve a century-old idea.

Nifty 50, Sensex today: The trends on Gift Nifty also indicate a gap-down start for the Indian benchmark index. The Gift Nifty was trading around 25,230 level, a discount of nearly 108 points from the ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.

Nigerian scientists achieve a major breakthrough in malaria drug research, depositing the first crystal structure of a key ...